Clinical Trials Browser

Phase 2 × Withdrawn × Iloprost × Clear all

NCT05411107 2024-05-17

Oral Iloprost for the Prevention of Lung Cancer In Former Smokers

Phase 2 Withdrawn

Lung Neoplasms, Pulmonary Disease, Chronic Obstructive